Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion

BACKGROUND: During the Chikungunya virus (CHIKV) epidemic on Ile de La Réunion, France, more than 30% of 750,000 inhabitants were infected. Local blood donation was suspended to prevent transfusion‐transmitted infection (TT‐CHIKV). To sustain the availability of platelet (PLT) components, the Établi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transfusion (Philadelphia, Pa.) Pa.), 2009-06, Vol.49 (6), p.1083-1091
Hauptverfasser: Rasonglès, Patrice, Angelini-Tibert, Marie France, Simon, Philip, Currie, Caroline, Isola, Herve, Kientz, Daniel, Slaedts, Marc, Jacquet, Michele, Sundin, David, Lin, Lily, Corash, Laurence, Cazenave, Jean Pierre
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1091
container_issue 6
container_start_page 1083
container_title Transfusion (Philadelphia, Pa.)
container_volume 49
creator Rasonglès, Patrice
Angelini-Tibert, Marie France
Simon, Philip
Currie, Caroline
Isola, Herve
Kientz, Daniel
Slaedts, Marc
Jacquet, Michele
Sundin, David
Lin, Lily
Corash, Laurence
Cazenave, Jean Pierre
description BACKGROUND: During the Chikungunya virus (CHIKV) epidemic on Ile de La Réunion, France, more than 30% of 750,000 inhabitants were infected. Local blood donation was suspended to prevent transfusion‐transmitted infection (TT‐CHIKV). To sustain the availability of platelet (PLT) components, the Établissement Français du Sang implemented universal pathogen inactivation (INTERCEPT, Cerus Europe BV) of PLT components (CPAs). The study assessed the safety of PLT components treated with pathogen inactivation transfused in routine clinical practice. STUDY DESIGN AND METHODS: This was a retrospective observational study using patient medical records and the AFSSAPS hemovigilance database (eFIT) to identify TT‐CHIKV and adverse events (AEs) classified as acute transfusion reactions (ATRs) to PLT components prepared with pathogen inactivation. RESULTS: During 1 year, 1950 INTERCEPT‐CPAs were transfused to 335 adult, 51 pediatric, and 41 infant patients. Nineteen AEs were observed in 15 patients and 10 were classified as ATRs. Eight ATRs occurred in 6 pediatric hematology‐oncology patients. No ATRs were observed in infants. The most frequently reported signs and symptoms were Grade 1 urticaria, itching, chills, fever, and anxiety. No cases of transfusion‐related acute lung injury, TT‐sepsis, or TT‐CHIKV were detected. CONCLUSIONS: INTERCEPT‐CPAs were well tolerated in a broad range of patients, including infants. ATR incidence was low and when present ATRs were of mild severity.
doi_str_mv 10.1111/j.1537-2995.2009.02111.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67536068</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20211196</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4671-9cb6aeadce9c7757753ee5cdd4142ec14c21b63aef20b14d7c1362701491f9ef3</originalsourceid><addsrcrecordid>eNqNkd-OEyEUxidG49bVVzDc6N2MwPyh3JiYxq3rNpo0NV4Sypxp6c7ACMxu-ya-gs_hi8m0Tb1UQsIJfN-Pk_MlCSI4I3G922WkzFlKOS8zijHPMI3X2f5JMrk8PE0mGBckJSSnV8kL73cYY8oxeZ5cEZ5jXrB8kvxcOWl8M3htDbIN6lsZoIWAlO16a8AEj3oHvXRQo0cdtqjf2mDVFjqtZIt6GbZ2AwZpI1XQDzKMoOBAhi6aUT04bTZIotlW3w9mM5iDRA_aDR5Br-uREq3otgVUA1pItPz9azCR8TJ51sjWw6vzeZ18u_m4mn1KF1_nt7MPi1QVFSMpV-tKgqwVcMVYGXcOUKq6LkhBQZFCUbKucgkNxWtS1EyRvKIMk4KThkOTXydvT9ze2R8D-CA67RW0rTRgBy-qSKxwNf2nkB4z4FUUTk9C5az3DhrRO91JdxAEizE-sRNjSmJMSYzxiaNV7KP19fmPYd1B_dd4zisK3pwF0sfxNzE8pf1FR0lFyqIce3h_0j3qFg7_3YBYLW-OZQSkJ4D2AfYXgHT3cSI5K8X3L3PB5ndsuZx-Fnf5HxztyZY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20211196</pqid></control><display><type>article</type><title>Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Rasonglès, Patrice ; Angelini-Tibert, Marie France ; Simon, Philip ; Currie, Caroline ; Isola, Herve ; Kientz, Daniel ; Slaedts, Marc ; Jacquet, Michele ; Sundin, David ; Lin, Lily ; Corash, Laurence ; Cazenave, Jean Pierre</creator><creatorcontrib>Rasonglès, Patrice ; Angelini-Tibert, Marie France ; Simon, Philip ; Currie, Caroline ; Isola, Herve ; Kientz, Daniel ; Slaedts, Marc ; Jacquet, Michele ; Sundin, David ; Lin, Lily ; Corash, Laurence ; Cazenave, Jean Pierre</creatorcontrib><description>BACKGROUND: During the Chikungunya virus (CHIKV) epidemic on Ile de La Réunion, France, more than 30% of 750,000 inhabitants were infected. Local blood donation was suspended to prevent transfusion‐transmitted infection (TT‐CHIKV). To sustain the availability of platelet (PLT) components, the Établissement Français du Sang implemented universal pathogen inactivation (INTERCEPT, Cerus Europe BV) of PLT components (CPAs). The study assessed the safety of PLT components treated with pathogen inactivation transfused in routine clinical practice. STUDY DESIGN AND METHODS: This was a retrospective observational study using patient medical records and the AFSSAPS hemovigilance database (eFIT) to identify TT‐CHIKV and adverse events (AEs) classified as acute transfusion reactions (ATRs) to PLT components prepared with pathogen inactivation. RESULTS: During 1 year, 1950 INTERCEPT‐CPAs were transfused to 335 adult, 51 pediatric, and 41 infant patients. Nineteen AEs were observed in 15 patients and 10 were classified as ATRs. Eight ATRs occurred in 6 pediatric hematology‐oncology patients. No ATRs were observed in infants. The most frequently reported signs and symptoms were Grade 1 urticaria, itching, chills, fever, and anxiety. No cases of transfusion‐related acute lung injury, TT‐sepsis, or TT‐CHIKV were detected. CONCLUSIONS: INTERCEPT‐CPAs were well tolerated in a broad range of patients, including infants. ATR incidence was low and when present ATRs were of mild severity.</description><identifier>ISSN: 0041-1132</identifier><identifier>EISSN: 1537-2995</identifier><identifier>DOI: 10.1111/j.1537-2995.2009.02111.x</identifier><identifier>PMID: 19309473</identifier><identifier>CODEN: TRANAT</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Alphavirus Infections - epidemiology ; Alphavirus Infections - prevention &amp; control ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood coagulation. Blood cells ; Blood Donors ; Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis ; Chikungunya virus ; Chikungunya virus - drug effects ; Chikungunya virus - radiation effects ; Child ; Child, Preschool ; Female ; France - epidemiology ; Fundamental and applied biological sciences. Psychology ; Furocoumarins - pharmacology ; Humans ; Infant ; Infant, Newborn ; Male ; Medical sciences ; Middle Aged ; Molecular and cellular biology ; Photochemistry ; Platelet ; Platelet Transfusion - adverse effects ; Retrospective Studies ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Ultraviolet Rays</subject><ispartof>Transfusion (Philadelphia, Pa.), 2009-06, Vol.49 (6), p.1083-1091</ispartof><rights>2009 American Association of Blood Banks</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4671-9cb6aeadce9c7757753ee5cdd4142ec14c21b63aef20b14d7c1362701491f9ef3</citedby><cites>FETCH-LOGICAL-c4671-9cb6aeadce9c7757753ee5cdd4142ec14c21b63aef20b14d7c1362701491f9ef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1537-2995.2009.02111.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1537-2995.2009.02111.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21615456$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19309473$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rasonglès, Patrice</creatorcontrib><creatorcontrib>Angelini-Tibert, Marie France</creatorcontrib><creatorcontrib>Simon, Philip</creatorcontrib><creatorcontrib>Currie, Caroline</creatorcontrib><creatorcontrib>Isola, Herve</creatorcontrib><creatorcontrib>Kientz, Daniel</creatorcontrib><creatorcontrib>Slaedts, Marc</creatorcontrib><creatorcontrib>Jacquet, Michele</creatorcontrib><creatorcontrib>Sundin, David</creatorcontrib><creatorcontrib>Lin, Lily</creatorcontrib><creatorcontrib>Corash, Laurence</creatorcontrib><creatorcontrib>Cazenave, Jean Pierre</creatorcontrib><title>Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion</title><title>Transfusion (Philadelphia, Pa.)</title><addtitle>Transfusion</addtitle><description>BACKGROUND: During the Chikungunya virus (CHIKV) epidemic on Ile de La Réunion, France, more than 30% of 750,000 inhabitants were infected. Local blood donation was suspended to prevent transfusion‐transmitted infection (TT‐CHIKV). To sustain the availability of platelet (PLT) components, the Établissement Français du Sang implemented universal pathogen inactivation (INTERCEPT, Cerus Europe BV) of PLT components (CPAs). The study assessed the safety of PLT components treated with pathogen inactivation transfused in routine clinical practice. STUDY DESIGN AND METHODS: This was a retrospective observational study using patient medical records and the AFSSAPS hemovigilance database (eFIT) to identify TT‐CHIKV and adverse events (AEs) classified as acute transfusion reactions (ATRs) to PLT components prepared with pathogen inactivation. RESULTS: During 1 year, 1950 INTERCEPT‐CPAs were transfused to 335 adult, 51 pediatric, and 41 infant patients. Nineteen AEs were observed in 15 patients and 10 were classified as ATRs. Eight ATRs occurred in 6 pediatric hematology‐oncology patients. No ATRs were observed in infants. The most frequently reported signs and symptoms were Grade 1 urticaria, itching, chills, fever, and anxiety. No cases of transfusion‐related acute lung injury, TT‐sepsis, or TT‐CHIKV were detected. CONCLUSIONS: INTERCEPT‐CPAs were well tolerated in a broad range of patients, including infants. ATR incidence was low and when present ATRs were of mild severity.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alphavirus Infections - epidemiology</subject><subject>Alphavirus Infections - prevention &amp; control</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood coagulation. Blood cells</subject><subject>Blood Donors</subject><subject>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</subject><subject>Chikungunya virus</subject><subject>Chikungunya virus - drug effects</subject><subject>Chikungunya virus - radiation effects</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>France - epidemiology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Furocoumarins - pharmacology</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Molecular and cellular biology</subject><subject>Photochemistry</subject><subject>Platelet</subject><subject>Platelet Transfusion - adverse effects</subject><subject>Retrospective Studies</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Ultraviolet Rays</subject><issn>0041-1132</issn><issn>1537-2995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkd-OEyEUxidG49bVVzDc6N2MwPyh3JiYxq3rNpo0NV4Sypxp6c7ACMxu-ya-gs_hi8m0Tb1UQsIJfN-Pk_MlCSI4I3G922WkzFlKOS8zijHPMI3X2f5JMrk8PE0mGBckJSSnV8kL73cYY8oxeZ5cEZ5jXrB8kvxcOWl8M3htDbIN6lsZoIWAlO16a8AEj3oHvXRQo0cdtqjf2mDVFjqtZIt6GbZ2AwZpI1XQDzKMoOBAhi6aUT04bTZIotlW3w9mM5iDRA_aDR5Br-uREq3otgVUA1pItPz9azCR8TJ51sjWw6vzeZ18u_m4mn1KF1_nt7MPi1QVFSMpV-tKgqwVcMVYGXcOUKq6LkhBQZFCUbKucgkNxWtS1EyRvKIMk4KThkOTXydvT9ze2R8D-CA67RW0rTRgBy-qSKxwNf2nkB4z4FUUTk9C5az3DhrRO91JdxAEizE-sRNjSmJMSYzxiaNV7KP19fmPYd1B_dd4zisK3pwF0sfxNzE8pf1FR0lFyqIce3h_0j3qFg7_3YBYLW-OZQSkJ4D2AfYXgHT3cSI5K8X3L3PB5ndsuZx-Fnf5HxztyZY</recordid><startdate>200906</startdate><enddate>200906</enddate><creator>Rasonglès, Patrice</creator><creator>Angelini-Tibert, Marie France</creator><creator>Simon, Philip</creator><creator>Currie, Caroline</creator><creator>Isola, Herve</creator><creator>Kientz, Daniel</creator><creator>Slaedts, Marc</creator><creator>Jacquet, Michele</creator><creator>Sundin, David</creator><creator>Lin, Lily</creator><creator>Corash, Laurence</creator><creator>Cazenave, Jean Pierre</creator><general>Blackwell Publishing Inc</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7U2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200906</creationdate><title>Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion</title><author>Rasonglès, Patrice ; Angelini-Tibert, Marie France ; Simon, Philip ; Currie, Caroline ; Isola, Herve ; Kientz, Daniel ; Slaedts, Marc ; Jacquet, Michele ; Sundin, David ; Lin, Lily ; Corash, Laurence ; Cazenave, Jean Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4671-9cb6aeadce9c7757753ee5cdd4142ec14c21b63aef20b14d7c1362701491f9ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alphavirus Infections - epidemiology</topic><topic>Alphavirus Infections - prevention &amp; control</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood coagulation. Blood cells</topic><topic>Blood Donors</topic><topic>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</topic><topic>Chikungunya virus</topic><topic>Chikungunya virus - drug effects</topic><topic>Chikungunya virus - radiation effects</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>France - epidemiology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Furocoumarins - pharmacology</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Molecular and cellular biology</topic><topic>Photochemistry</topic><topic>Platelet</topic><topic>Platelet Transfusion - adverse effects</topic><topic>Retrospective Studies</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Ultraviolet Rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rasonglès, Patrice</creatorcontrib><creatorcontrib>Angelini-Tibert, Marie France</creatorcontrib><creatorcontrib>Simon, Philip</creatorcontrib><creatorcontrib>Currie, Caroline</creatorcontrib><creatorcontrib>Isola, Herve</creatorcontrib><creatorcontrib>Kientz, Daniel</creatorcontrib><creatorcontrib>Slaedts, Marc</creatorcontrib><creatorcontrib>Jacquet, Michele</creatorcontrib><creatorcontrib>Sundin, David</creatorcontrib><creatorcontrib>Lin, Lily</creatorcontrib><creatorcontrib>Corash, Laurence</creatorcontrib><creatorcontrib>Cazenave, Jean Pierre</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Transfusion (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rasonglès, Patrice</au><au>Angelini-Tibert, Marie France</au><au>Simon, Philip</au><au>Currie, Caroline</au><au>Isola, Herve</au><au>Kientz, Daniel</au><au>Slaedts, Marc</au><au>Jacquet, Michele</au><au>Sundin, David</au><au>Lin, Lily</au><au>Corash, Laurence</au><au>Cazenave, Jean Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion</atitle><jtitle>Transfusion (Philadelphia, Pa.)</jtitle><addtitle>Transfusion</addtitle><date>2009-06</date><risdate>2009</risdate><volume>49</volume><issue>6</issue><spage>1083</spage><epage>1091</epage><pages>1083-1091</pages><issn>0041-1132</issn><eissn>1537-2995</eissn><coden>TRANAT</coden><abstract>BACKGROUND: During the Chikungunya virus (CHIKV) epidemic on Ile de La Réunion, France, more than 30% of 750,000 inhabitants were infected. Local blood donation was suspended to prevent transfusion‐transmitted infection (TT‐CHIKV). To sustain the availability of platelet (PLT) components, the Établissement Français du Sang implemented universal pathogen inactivation (INTERCEPT, Cerus Europe BV) of PLT components (CPAs). The study assessed the safety of PLT components treated with pathogen inactivation transfused in routine clinical practice. STUDY DESIGN AND METHODS: This was a retrospective observational study using patient medical records and the AFSSAPS hemovigilance database (eFIT) to identify TT‐CHIKV and adverse events (AEs) classified as acute transfusion reactions (ATRs) to PLT components prepared with pathogen inactivation. RESULTS: During 1 year, 1950 INTERCEPT‐CPAs were transfused to 335 adult, 51 pediatric, and 41 infant patients. Nineteen AEs were observed in 15 patients and 10 were classified as ATRs. Eight ATRs occurred in 6 pediatric hematology‐oncology patients. No ATRs were observed in infants. The most frequently reported signs and symptoms were Grade 1 urticaria, itching, chills, fever, and anxiety. No cases of transfusion‐related acute lung injury, TT‐sepsis, or TT‐CHIKV were detected. CONCLUSIONS: INTERCEPT‐CPAs were well tolerated in a broad range of patients, including infants. ATR incidence was low and when present ATRs were of mild severity.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>19309473</pmid><doi>10.1111/j.1537-2995.2009.02111.x</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1132
ispartof Transfusion (Philadelphia, Pa.), 2009-06, Vol.49 (6), p.1083-1091
issn 0041-1132
1537-2995
language eng
recordid cdi_proquest_miscellaneous_67536068
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adolescent
Adult
Aged
Aged, 80 and over
Alphavirus Infections - epidemiology
Alphavirus Infections - prevention & control
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Blood coagulation. Blood cells
Blood Donors
Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis
Chikungunya virus
Chikungunya virus - drug effects
Chikungunya virus - radiation effects
Child
Child, Preschool
Female
France - epidemiology
Fundamental and applied biological sciences. Psychology
Furocoumarins - pharmacology
Humans
Infant
Infant, Newborn
Male
Medical sciences
Middle Aged
Molecular and cellular biology
Photochemistry
Platelet
Platelet Transfusion - adverse effects
Retrospective Studies
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Ultraviolet Rays
title Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T21%3A43%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transfusion%20of%20platelet%20components%20prepared%20with%20photochemical%20pathogen%20inactivation%20treatment%20during%20a%20Chikungunya%20virus%20epidemic%20in%20Ile%20de%20La%20R%C3%A9union&rft.jtitle=Transfusion%20(Philadelphia,%20Pa.)&rft.au=Rasongl%C3%A8s,%20Patrice&rft.date=2009-06&rft.volume=49&rft.issue=6&rft.spage=1083&rft.epage=1091&rft.pages=1083-1091&rft.issn=0041-1132&rft.eissn=1537-2995&rft.coden=TRANAT&rft_id=info:doi/10.1111/j.1537-2995.2009.02111.x&rft_dat=%3Cproquest_cross%3E20211196%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20211196&rft_id=info:pmid/19309473&rfr_iscdi=true